TY - JOUR
T1 - Extracellular Ca2+-sensing receptor is a promiscuous divalent cation sensor that responds to lead
AU - Handlogten, Mary E.
AU - Shiraishi, Naoki
AU - Awata, Hisataka
AU - Huang, Chunfa
AU - Miller, R. Tyler
PY - 2000
Y1 - 2000
N2 - The extracellular Ca2+-sensing receptor (CaR) responds to polycations, including Ca2+ and neomycin. This receptor is a physiological regulator of systemic Ca2+ metabolism and may also mediate the toxic effects of hypercalcemia. A number of divalent cations, including Pb2+, Co2+, Cd2+, and Fe2+, are toxic to the kidney, brain, and other tissues where the CaR is expressed. To determine which divalent cations can activate the CaR, we expressed the human CaR in HEK-293 cells and measured activation of phospholipase A2 (PLA2) and the mitogen-activated protein kinase p42ERK in response to potential agonists for the receptor. HEK-293 cells expressing the nonfunctional mutant CaR R796W served as controls. Extracellular Ca2+, Ba2+, Cd2+, Co2+, Fe2+, Gd3+, Ni2+, Pb2+, and neomycin activated the CaR, but Hg2+ and Fe3+ did not. We analyzed the kinetics of activation of p42ERK and PLA2 by the CaR in response to Ca2+, Co2+, and Pb2+. The EC50 values ranged from ~0.1 mM for Pb2+ to ~4.0 mM for Ca2+. The Hill coefficients were >3, indicating multiple cooperative ligand binding sites or subunits. Submaximal concentrations of Ca2+ and Pb2+ were additive for activation of the CaR. The EC50 for Ca2+ or Pb2+ was reduced four- to fivefold by the presence of the other ion. These divalent cations also activated PLA2 via the CaR in Madin-Darby canine kidney cells that stably express the CaR. We conclude that many divalent cations activate the CaR and that their effects are additive. The facts that the CaR is a promiscuous polycation sensor and that the effects of these ions are additive to activate it suggest that the CaR may contribute to the toxicity of some heavy metals such as Pb2+, Cd2+, Co2+, and Fe2+ for the kidney and other tissues where it is expressed.
AB - The extracellular Ca2+-sensing receptor (CaR) responds to polycations, including Ca2+ and neomycin. This receptor is a physiological regulator of systemic Ca2+ metabolism and may also mediate the toxic effects of hypercalcemia. A number of divalent cations, including Pb2+, Co2+, Cd2+, and Fe2+, are toxic to the kidney, brain, and other tissues where the CaR is expressed. To determine which divalent cations can activate the CaR, we expressed the human CaR in HEK-293 cells and measured activation of phospholipase A2 (PLA2) and the mitogen-activated protein kinase p42ERK in response to potential agonists for the receptor. HEK-293 cells expressing the nonfunctional mutant CaR R796W served as controls. Extracellular Ca2+, Ba2+, Cd2+, Co2+, Fe2+, Gd3+, Ni2+, Pb2+, and neomycin activated the CaR, but Hg2+ and Fe3+ did not. We analyzed the kinetics of activation of p42ERK and PLA2 by the CaR in response to Ca2+, Co2+, and Pb2+. The EC50 values ranged from ~0.1 mM for Pb2+ to ~4.0 mM for Ca2+. The Hill coefficients were >3, indicating multiple cooperative ligand binding sites or subunits. Submaximal concentrations of Ca2+ and Pb2+ were additive for activation of the CaR. The EC50 for Ca2+ or Pb2+ was reduced four- to fivefold by the presence of the other ion. These divalent cations also activated PLA2 via the CaR in Madin-Darby canine kidney cells that stably express the CaR. We conclude that many divalent cations activate the CaR and that their effects are additive. The facts that the CaR is a promiscuous polycation sensor and that the effects of these ions are additive to activate it suggest that the CaR may contribute to the toxicity of some heavy metals such as Pb2+, Cd2+, Co2+, and Fe2+ for the kidney and other tissues where it is expressed.
KW - Cell signaling
KW - Divalent cation
KW - G protein-coupled receptor
KW - Mitogen-activated protein kinase
KW - Phospholipase A
UR - http://www.scopus.com/inward/record.url?scp=0034544747&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034544747&partnerID=8YFLogxK
U2 - 10.1152/ajprenal.2000.279.6.f1083
DO - 10.1152/ajprenal.2000.279.6.f1083
M3 - Article
C2 - 11097627
AN - SCOPUS:0034544747
SN - 0363-6135
VL - 279
SP - F1083-F1091
JO - American Journal of Physiology - Heart and Circulatory Physiology
JF - American Journal of Physiology - Heart and Circulatory Physiology
IS - 6 48-6
ER -